FEB 23, 2017 12:00 PM PST

Recent progress in cellular medicine with an eye to precision medicine

Speaker

Abstract

Despite vast investment for decades in cancer research and development, cancer is still among the leading causes of death worldwide and its toll is expected to rise by about 70% over the next two decades. There are many aspects of cancer, including its complexity, diversity, and dynamic nature, which call for a radical change in the way we approach cancer study and management. For instance, the genetic profile of tumors affects patient tumor response while the tumor microenvironment plays a critical role in cancer development, progression, and control. Due to intra-tumoral heterogeneity, cancer cells extracted from the same tumor of a patient may be genetically heterogeneous. Tumor/host immune interactions influences disease outcome by altering the balance of suppressive versus cytotoxic responses in the vicinity of the tumor. In addition, biopsies often suffer from sample bias, and tumor sampling from some cancer types still remains difficult resulting in insufficient amount of tissue for genetic testing. Considering the high tumor heterogeneity from individual patients, it is increasingly recognized that a personalized medicine approach would help identifying the optimal treatment regimen for an individual patient, calibrated on his/her specific cancer signature, reducing toxicity from overtreatment and increasing efficacy of therapy.

However, in order to pursue personalized approaches, novel approaches capable of improving the care of cancer patients through earlier detection, better therapy monitoring, new drug development and rational treatment planning are urgently needed.

One of the challenges of personalized medicine is related to the so-called liquid biopsy, that is the extraction of circulating tumor cells (CTC) and cell-free or circulating tumor DNA (ctDNA) from peripheral blood, which is expected to revolutionize the way in which cancer care works nowadays, by providing easy and repeatable access to tumor biological material, and consequently to the information about disease state, prognosis and chemo-sensitivity contained in it. On the other hand, also because of the epithelial-to-mesenchymal transition, not much is known at present about how the peripheral blood samples the tumor material, adding urgency to the type of study discussed above. Another challenge of personalized medicine is represented by the assembly of suitable in vitro tumor models capable of predicting the response to specific chemotherapeutic agents for each patient. I will present to you today a new method to recognize, count, sort and analyze CTCs.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
JUN 03, 2021 8:00 AM PDT
JUN 03, 2021 8:00 AM PDT
Date: June 3, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Molecular combing provides unbiased quantification and characterization of DNA structure and dynamics by imaging single DN...
SEP 29, 2021 11:00 AM PDT
C.E. CREDITS
SEP 29, 2021 11:00 AM PDT
Date: Septembr 29, 2021 Time: 11:00am (PDT), 2:00pm (EDT) 3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. While...
FEB 23, 2017 12:00 PM PST

Recent progress in cellular medicine with an eye to precision medicine


Specialty

Research And Development

Gene Expression

Dna

Big Data

Cancer Research

Tumor

Biomarkers

Cancer

Earth Science

Oncology

University

Gene Sequencing

Drug Discovery

Mass Cytometry

Cell Culture

Geography

Asia50%

Europe50%

Registration Source

Website Visitors100%

Job Title

Student50%

Medical Laboratory Technician50%

Organization

Manufacturer - Other50%

Academic Institution50%


Show Resources
Loading Comments...
Show Resources